Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. $BTC: Peter Schiff Calls Bitcoin Trading Above $21K a “Sucker’s Rally”
  2. World Markets At This Hour
  3. New Survey Shows Nearly 50% Of Millennials And Gen Z Want Bitcoin, Cryptos In Their Retirement Fund
  4. Bitcoin’s Price Wavers After The Release of New Inflation Data
  5. K33 Research Highlights Unwavering Institutional Demand for Bitcoin